ARMP - Armata Pharmaceuticals - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

130.3M

Cash

12.46M

Avg Qtr Burn

-12.61M

Short % of Float

1.22%

Insider Ownership

69.59%

Institutional Own.

3.45%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AP-PA02 Details Cystic fibrosis	Phase 2/3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AP-PA02 Details Non-Cystic Fibrosis Bronchiectasis	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AP-SA02 Details Bacterial infection	Phase 2a Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.